FRONTIERS IN BIOSCIENCE
Balance Sheet
Fiscal Year: 2025
Assets in 2025 (Year End)
$8,977,418
Property, Plant, & Equipment (net)
64%
Cash & Equivalents
36%
Investments
<1%
Prepaid Expenses
<1%
Receivables (Non-Related)
0%
Related-Party Receivables
0%
Inventories
0%
Other Assets
0%
Liabilities in 2025 (Year End)
$246,462
Related-Party Payables
95%
Other Liabilities
5%
Payables & Accruals
0%
Grants Payable
0%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Assets
2024
2025
Change
Cash & Equivalents
$3,283,357
$3,266,405
-1%
Receivables (Non-Related)
-
-
-
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$6,045
$4,372
-28%
Investments
$5,481
$5,484
+0%
Property, Plant, & Equipment (net)
$5,810,376
$5,701,157
-2%
Other Assets
$42,000
-
-
Total Assets
$9,147,259
$8,977,418
-2%
Liabilities
2024
2025
Change
Payables & Accruals
-
-
-
Grants Payable
-
-
-
Deferred Revenue
-
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
$233,187
$233,187
+0%
Other Liabilities
$10,861
$13,275
+22%
Total Liabilities
$244,048
$246,462
+1%
Net assets
2024
2025
Change
Restricted Net Assets
-
-
-
Unrestricted Net Assets
$8,903,211
$8,730,956
-2%
Net assets
2024
2025
Change
Net assets
+$8,903,211
+$8,730,956
-2%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)